How do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding?
A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.
The results indicated the risk of intraocular bleeding was reduced by one-fifth with newer anticoagulants, compared with warfarin. This was especially relevant for patients with a higher risk of spontaneous retinal and subretinal hemorrhage.
